SCHEMBL753053

SCHEMBL753053

C[C@@H](c1ccc(-c2ccc(Cl)c(C(=O)O)c2)cc1Cl)[C@](O)(c1ccc(=O)n(C)c1)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.35
GRIA1 P42261 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35
GRIK2 Q13002 1/20 0.35
GRIK3 Q13003 1/20 0.35
DPP4 P27487 3/20 0.35
DPP7 Q9UHL4 3/20 0.35
AKR1C2 P52895 3/20 0.35
AKR1C1 Q04828 3/20 0.35
SYK P43405 2/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
XDH P47989 1/20 0.32
PDE2A O00408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL732991 1.00 GRIK1 (0.35) GRIK1GRIA1GRIA2GRIA3GRIA4
SCHEMBL755587 0.93 PDK2 (0.36) DPP4DPP7AKR1C2AKR1C1XDH
SCHEMBL734223 0.93 PDK2 (0.36) DPP4DPP7AKR1C2AKR1C1XDH
SCHEMBL480062 0.93 DPP4 (0.34) DPP4DPP7AKR1C2AKR1C1MRGPRX4
SCHEMBL754902 0.93 DPP4 (0.34) DPP4DPP7AKR1C2AKR1C1MRGPRX4
SCHEMBL732428 0.91 DPP4 (0.34) DPP4DPP7AKR1C2AKR1C1PDE2A
SCHEMBL755583 0.91 DPP4 (0.34) DPP4DPP7AKR1C2AKR1C1PDE2A
SCHEMBL755590 0.88 ESR1 (0.35) DPP4DPP7AKR1C2
SCHEMBL733422 0.88 ESR1 (0.35) DPP4DPP7AKR1C2
SCHEMBL15789773 0.86 DPP4 (0.34) DPP4DPP7PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 GRIK1 357/4885GRIA1 68/4885GRIA2 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.